創薬アウトソーシングサービス市場：サービスタイプ別、薬剤タイプ別、疾患モデル別、治療領域別、世界予測（2023-2032年）

創薬アウトソーシングサービス市場規模は、遺伝子治療やモノクローナル抗体を含む生物製剤の急速な進歩により、2023年から2032年にかけてCAGR 8.2%を記録する見通しです。

個々の患者に対応するための新規生物製剤や個別化医療ソリューションの開発が急ピッチで進んでいることが、バイオ医薬品の研究開発活動におけるアウトソーシングサービスの需要拡大につながっています。一例を挙げると、2021年1月、チャールズ・リバー・ラボラトリーズ・インターナショナルは、バイオ医薬品サービスプロバイダーであるJADE Biomedicalと提携し、細胞・遺伝子療法を中心とする生物製剤治療への需要に対応しつつ、世界な生物製剤試験能力を拡大しました。アウトソーシング・プロバイダーが、臨床研究の効率向上のため、実環境に即したエビデンスの創出や患者中心の試験デザインなどのサービスに重点を置くようになっていることも、市場の成長に寄与しています。

創薬アウトソーシングサービス業界は、サービスタイプ、薬剤タイプ、疾患モデル、治療領域、地域によって区分されます。

サービスタイプ別では、化学サービスの市場規模が2023～2032年に顕著なCAGRを記録します。創薬アウトソーシング化学サービスは、医薬品・バイオテクノロジー業界において、医薬品開発プロセスの合理化と迅速化において極めて重要な役割を果たしています。また、仮想スクリーニング、分子モデリング、構造ベースの薬剤設計などの用途に対応する計算化学サービスのアウトソーシングの重要性が高まっていることも、同分野の成長に寄与しています。

治療分野別では、神経分野の創薬アウトソーシングサービス産業は2032年まで拡大すると予測されます。この成長は、アルツハイマー病、パーキンソン病、多発性硬化症の負担増と、それに伴う効果的な治療法の開発ニーズによるものと考えられます。研究開発活動の迅速化、コスト削減、専門的知識へのアクセス向上は、神経学創薬サービスをアウトソーシングする利点の一部です。

地域別では、APACの創薬アウトソーシング市場規模が2032年まで顕著なCAGRを示すと予測されています。これは、豊富な人材プール、費用対効果の高い労働力、良好な規制環境の存在によるものです。コスト削減、専門知識へのアクセス、医薬品開発プロセスの迅速化といったニーズの高まりにより、多くの製薬企業やバイオテクノロジー企業が創薬サービスのアウトソーシングに目を向けざるを得なくなっています。知的財産、臨床試験、データセキュリティに関する規制状況の進展も、この地域の業界成長に拍車をかけると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 創薬アウトソーシングサービス業界考察

• エコシステム分析
• 業界への影響要因
  • 促進要因
    • 世界の慢性疾患の蔓延
    • 新薬や治療薬のアウトソーシング需要の増加
    • 製薬・バイオテクノロジー企業による研究開発費の増加
    • 創薬技術の進歩
  • 業界の潜在的リスク＆課題
    • 知的財産に関する懸念
• 成長の可能性分析
• COVID-19影響分析
• 規制状況
  • 米国
  • 欧州
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
  • Pharmaceutical Product Development（Thermo Fisher Scientific, Inc.）
  • Laboratory Corporation of America Holdings（Covance Inc.）
  • IQVIA（Quintiles IMS Holdings, Inc.）
  • Eurofins Scientific
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• 戦略ダッシュボード

第5章 創薬アウトソーシングサービス市場：サービスタイプ別、2018年～2032年

• 主要動向：サービスタイプ別
• 化学サービス
• バイオサービス

第6章 創薬アウトソーシングサービス市場：薬剤タイプ別、2018年～2032年

• 主要動向：薬剤タイプ別
• 低分子医薬品
• 高分子医薬品

第7章 創薬アウトソーシングサービス市場：疾患モデル別、2018年～2032年

• 主要動向：疾患モデル別
• 試験管内モデル
• 動物モデル
• 細胞モデル
• その他の疾患モデル

第8章 創薬アウトソーシングサービス市場：治療領域別、2018年～2032年

• 主要動向：治療領域別
• 糖尿病
• 神経
• オンコロジー
• 感染症
• その他の治療領域

第9章 創薬アウトソーシングサービス市場：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第10章 企業プロファイル

• Charles River Laboratories International, Inc.
• IQVIA（Quintiles IMS Holdings, Inc.）
• Laboratory Corporation of America Holdings（Covance Inc.）
• Pharmaceutical Product Development（Thermo Fisher Scientific, Inc.）
• WuXi AppTec
• Eurofins Scientific
• GenScript ProBio（Genscript Biotech Corporation）
• Aragen Life Sciences Ltd.
• Syngene International Limited
• Aurigene Pharmaceutical Services Ltd.
• Pharmaron
• Shanghai ChemPartner
• Jubilant Biosys Ltd（Jubilant Pharmova Limited）

Data Tables

• TABLE 1 Market revenue, by service type (2022)
• TABLE 2 Market revenue, by drug type (2022)
• TABLE 3 Market revenue, by disease model (2022)
• TABLE 4 Market revenue, by therapeutic area (2022)
• TABLE 5 Global drug discovery outsourcing services market size, by region, 2018 - 2024 (USD Million)
• TABLE 6 Global drug discovery outsourcing services market size, by region, 2025 - 2032 (USD Million)
• TABLE 7 Global drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 8 Global drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 9 Global drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 10 Global drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 11 Global drug discovery outsourcing services market size, by disease model, 2018 - 2024 (USD Million)
• TABLE 12 Global drug discovery outsourcing services market size, by disease model, 2025 - 2032 (USD Million)
• TABLE 13 Global drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 14 Global drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 15 Industry impact forces
• TABLE 16 Competitive benchmarking of major market players
• TABLE 17 Competitive positioning matrix: Classification criteria
• TABLE 18 Chemistry services market size, 2018 - 2024 (USD Million)
• TABLE 19 Chemistry services market size, 2025 - 2032 (USD Million)
• TABLE 20 Biological services market size, 2018 - 2024 (USD Million)
• TABLE 21 Biological services market size, 2025 - 2032 (USD Million)
• TABLE 22 Small-molecule drugs market size, 2018 - 2024 (USD Million)
• TABLE 23 Small-molecule drugs market size, 2025 - 2032 (USD Million)
• TABLE 24 Large-molecule drugs market size, 2018 - 2024 (USD Million)
• TABLE 25 Large-molecule drugs market size, 2025 - 2032 (USD Million)
• TABLE 26 In vitro models market size, 2018 - 2024 (USD Million)
• TABLE 27 In vitro models market size, 2025 - 2032 (USD Million)
• TABLE 28 Animal models market size, 2018 - 2024 (USD Million)
• TABLE 29 Animal models market size, 2025 - 2032 (USD Million)
• TABLE 30 Cellular models market size, 2018 - 2024 (USD Million)
• TABLE 31 Cellular models market size, 2025 - 2032 (USD Million)
• TABLE 32 Other disease models market size, 2018 - 2024 (USD Million)
• TABLE 33 Other disease models market size, 2025 - 2032 (USD Million)
• TABLE 34 Diabetes market size, 2018 - 2024 (USD Million)
• TABLE 35 Diabetes market size, 2025 - 2032 (USD Million)
• TABLE 36 Neurology market size, 2018 - 2024 (USD Million)
• TABLE 37 Neurology market size, 2025 - 2032 (USD Million)
• TABLE 38 Oncology market size, 2018 - 2024 (USD Million)
• TABLE 39 Oncology market size, 2025 - 2032 (USD Million)
• TABLE 40 Infectious diseases market size, 2018 - 2024 (USD Million)
• TABLE 41 Infectious diseases market size, 2025 - 2032 (USD Million)
• TABLE 42 Other therapeutic areas market size, 2018 - 2024 (USD Million)
• TABLE 43 Other therapeutic areas market size, 2025 - 2032 (USD Million)
• TABLE 44 North America drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 45 North America drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 46 North America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 47 North America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 48 North America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 49 North America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 50 North America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 51 North America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 52 North America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 53 North America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 54 U.S. drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 55 U.S. drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 56 U.S. drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 57 U.S. drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 58 U.S. drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 59 U.S. drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 60 U.S. drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 61 U.S. drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 62 Canada drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 63 Canada drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 64 Canada drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 65 Canada drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 66 Canada drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 67 Canada drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 68 Canada drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 69 Canada drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 70 Europe drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 71 Europe drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 72 Europe drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 73 Europe drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 74 Europe drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 75 Europe drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 76 Europe drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 77 Europe drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 78 Europe drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 79 Europe drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 80 Germany drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 81 Germany drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 82 Germany drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 83 Germany drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 84 Germany drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 85 Germany drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 86 Germany drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 87 Germany drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 88 UK drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 89 UK drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 90 UK drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 91 UK drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 92 UK drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 93 UK drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 94 UK drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 95 UK drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 96 France drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 97 France drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 98 France drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 99 France drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 100 France drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 101 France drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 102 France drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 103 France drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 104 Italy drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 105 Italy drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 106 Italy drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 107 Italy drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 108 Italy drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 109 Italy drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 110 Italy drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 111 Italy drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 112 Spain drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 113 Spain drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 114 Spain drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 115 Spain drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 116 Spain drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 117 Spain drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 118 Spain drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 119 Spain drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 120 Rest of Europe drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 121 Rest of Europe drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 122 Rest of Europe drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 123 Rest of Europe drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 124 Rest of Europe drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 125 Rest of Europe drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 126 Rest of Europe drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 127 Rest of Europe drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 128 Asia Pacific drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 129 Asia Pacific drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 130 Asia Pacific drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 131 Asia Pacific drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 132 Asia Pacific drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 133 Asia Pacific drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 134 Asia Pacific drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 135 Asia Pacific drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 136 Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 137 Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 138 China drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 139 China drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 140 China drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 141 China drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 142 China drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 143 China drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 144 China drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 145 China drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 146 Japan discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 147 Japan discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 148 Japan discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 149 Japan discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 150 Japan discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 151 Japan discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 152 Japan discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 153 Japan discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 154 India drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 155 India drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 156 India drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 157 India drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 158 India drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 159 India drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 160 India drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 161 India drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 162 Australia drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 163 Australia drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 164 Australia drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 165 Australia drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 166 Australia drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 167 Australia drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 168 Australia drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 169 Australia drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 170 Rest of Asia Pacific drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 171 Rest of Asia Pacific drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 172 Rest of Asia Pacific drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 173 Rest of Asia Pacific drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 174 Rest of Asia Pacific drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 175 Rest of Asia Pacific drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 176 Rest of Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 177 Rest of Asia Pacific drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 178 Latin America drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 179 Latin America drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 180 Latin America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 181 Latin America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 182 Latin America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 183 Latin America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 184 Latin America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 185 Latin America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 186 Latin America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 187 Latin America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 188 Brazil drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 189 Brazil drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 190 Brazil drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 191 Brazil drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 192 Brazil drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 193 Brazil drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 194 Brazil drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 195 Brazil drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 196 Mexico discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 197 Mexico discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 198 Mexico discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 199 Mexico discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 200 Mexico discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 201 Mexico discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 202 Mexico discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 203 Mexico discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 204 Rest of Latin America drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 205 Rest of Latin America drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 206 Rest of Latin America drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 207 Rest of Latin America drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 208 Rest of Latin America drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 209 Rest of Latin America drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 210 Rest of Latin America drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 211 Rest of Latin America drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 212 Middle East & Africa drug discovery outsourcing services market size, by country, 2018 - 2024 (USD Million)
• TABLE 213 Middle East & Africa drug discovery outsourcing services market size, by country, 2025 - 2032 (USD Million)
• TABLE 214 Middle East & Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 215 Middle East & Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 216 Middle East & Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 217 Middle East & Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 218 Middle East & Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 219 Middle East & Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 220 Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 221 Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 222 South Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 223 South Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 224 South Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 225 South Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 226 South Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 227 South Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 228 South Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 229 South Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 230 Saudi Arabia discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 231 Saudi Arabia discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 232 Saudi Arabia discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 233 Saudi Arabia discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 234 Saudi Arabia discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 235 Saudi Arabia discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 236 Saudi Arabia discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 237 Saudi Arabia discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)
• TABLE 238 Rest of Middle East & Africa drug discovery outsourcing services market size, by service type, 2018 - 2024 (USD Million)
• TABLE 239 Rest of Middle East & Africa drug discovery outsourcing services market size, by service type, 2025 - 2032 (USD Million)
• TABLE 240 Rest of Middle East & Africa drug discovery outsourcing services market size, by drug type, 2018 - 2024 (USD Million)
• TABLE 241 Rest of Middle East & Africa drug discovery outsourcing services market size, by drug type, 2025 - 2032 (USD Million)
• TABLE 242 Rest of Middle East & Africa drug discovery outsourcing services market size, by disease models, 2018 - 2024 (USD Million)
• TABLE 243 Rest of Middle East & Africa drug discovery outsourcing services market size, by disease models, 2025 - 2032 (USD Million)
• TABLE 244 Rest of Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2018 - 2024 (USD Million)
• TABLE 245 Rest of Middle East & Africa drug discovery outsourcing services market size, by therapeutic area, 2025 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Profile break-up of primary respondents
• FIG 6 Drug discovery outsourcing services 360 degree synopsis, 2018 - 2032
• FIG 7 Industry ecosystem analysis
• FIG 8 Growth potential analysis, by service type
• FIG 9 Growth potential analysis, by drug type
• FIG 10 Growth potential analysis, by disease model
• FIG 11 Growth potential analysis, by therapeutic area
• FIG 12 Porter's analysis
• FIG 13 PESTEL analysis
• FIG 14 Company matrix analysis, 2022
• FIG 15 Competitive analysis of major market players
• FIG 16 Competitive positioning matrix, 2022
• FIG 17 Strategy dashboard, 2022

Drug Discovery Outsourcing Services Market size is poised to record 8.2% CAGR from 2023-2032, on account of the rapid advances in biologics, including gene therapies and monoclonal antibodies.

The surging developments in novel biologics and personalized medicine solutions to cater to individual patients is leading to the greater demand for outsourcing services in biopharmaceutical R&D activities. To cite an instance, in January 2021, Charles River Laboratories International partnered with biopharma service provider JADE Biomedical to expand its global biologics testing capabilities while accommodating the demand for biologics therapeutics, mainly cell and gene therapies. The growing focus of outsourcing providers on services, such as real-world evidence generation as well as patient-centric trial designs for improved efficiency of clinical research will also contribute to the market growth.

The drug discovery outsourcing services industry is segmented based on service type, drug type, disease model, therapeutic area, and region.

In terms of service type, the market size from the chemistry services segment will record appreciable CAGR from 2023-2032. Drug discovery outsourcing chemistry services are playing pivotal role in the pharmaceutical and biotechnology industries in streamlining and expediting the drug development process. The surging importance of outsourcing computational chemistry services to cater to uses in virtual screening, molecular modeling, and structure-based drug design will also contribute to the segment growth.

On the basis of therapeutic area, the drug discovery outsourcing services industry value from the neurology segment is projected to expand up to 2032. The growth can be attributed to the higher burden of Alzheimer's disease, Parkinson's disease, and multiple sclerosis along with the subsequent need for the development of their effective treatments. Accelerated R&D activities, reduces costs, and the improved access to specialized expertise are some advantages of outsourcing neurology drug discovery services.

Regionally, the APAC drug discovery outsourcing services market size is projected to observe notable CAGR through 2032 due to the presence of large talent pools, cost-effective labor, and favorable regulatory environments. The surging need for reducing costs, accessing specialized expertise, and accelerating the drug development process has compelled numerous pharmaceutical and biotechnology companies to turn to outsourcing for drug discovery services. The evolving regulatory landscape related to intellectual property, clinical trials, and data security will also add to the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Drug discovery outsourcing services industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Service type trends
  • 2.1.4 Drug type trends
  • 2.1.5 Disease model trends
  • 2.1.6 Therapeutic area trends

Chapter 3 Drug Discovery Outsourcing Services Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of chronic diseases globally
    • 3.2.1.2 Increasing demand for outsourcing novel drugs and therapeutics
    • 3.2.1.3 Increasing R&D expenditure by pharmaceutical and biotechnology companies
    • 3.2.1.4 Increasing technological advancements in drug discovery
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Intellectual property concerns
• 3.3 Growth potential analysis
  • 3.3.1 By service type
  • 3.3.2 By drug type
  • 3.3.3 By disease model
  • 3.3.4 By therapeutic area
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
  • 4.1.2 Laboratory Corporation of America Holdings (Covance Inc.)
  • 4.1.3 IQVIA (Quintiles IMS Holdings, Inc.)
  • 4.1.4 Eurofins Scientific
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategy dashboard, 2022

Chapter 5 Drug Discovery Outsourcing Services Market, By Service Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by service type
• 5.2 Chemistry services
• 5.3 Biological services

Chapter 6 Drug Discovery Outsourcing Services Market, By Drug Type, 2018 - 2032 (USD Million)

• 6.1 Key trends, by drug type
• 6.2 Small-molecule drugs
• 6.3 Large-molecule drugs

Chapter 7 Drug Discovery Outsourcing Services Market, By Disease Model, 2018 - 2032 (USD Million)

• 7.1 Key trends, by disease model
• 7.2 In vitro models
• 7.3 Animal models
• 7.4 Cellular models
• 7.5 Other disease models

Chapter 8 Drug Discovery Outsourcing Services Market, By Therapeutic Area, 2018 - 2032 (USD Million)

• 8.1 Key trends, by therapeutic area
• 8.2 Diabetes
• 8.3 Neurology
• 8.4 Oncology
• 8.5 Infectious diseases
• 8.6 Other therapeutic areas

Chapter 9 Drug Discovery Outsourcing Services Market, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Charles River Laboratories International, Inc.
• 10.2 IQVIA (Quintiles IMS Holdings, Inc.)
• 10.3 Laboratory Corporation of America Holdings (Covance Inc.)
• 10.4 Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
• 10.5 WuXi AppTec
• 10.6 Eurofins Scientific
• 10.7 GenScript ProBio (Genscript Biotech Corporation)
• 10.8 Aragen Life Sciences Ltd.
• 10.9 Syngene International Limited
• 10.10 Aurigene Pharmaceutical Services Ltd.
• 10.11 Pharmaron
• 10.12 Shanghai ChemPartner
• 10.13 Jubilant Biosys Ltd (Jubilant Pharmova Limited)